| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
| Ausblick | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Analysen zu Novartis AG
| 26.09.23 | Novartis Buy | Deutsche Bank AG | |
| 25.09.23 | Novartis Equal-weight | Morgan Stanley | |
| 22.09.23 | Novartis Buy | Deutsche Bank AG | |
| 08.09.23 | Novartis Buy | Deutsche Bank AG | |
| 05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.09.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.08.23 | Novartis Buy | Deutsche Bank AG | |
| 10.08.23 | Novartis Underweight | Barclays Capital | |
| 19.07.23 | Novartis Buy | Deutsche Bank AG | |
| 19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.07.23 | Novartis Neutral | UBS AG | |
| 18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.07.23 | Novartis Buy | Jefferies & Company Inc. | |
| 10.07.23 | Novartis Buy | Deutsche Bank AG | |
| 05.07.23 | Novartis Buy | Jefferies & Company Inc. | |
| 15.06.23 | Novartis Underweight | Barclays Capital | |
| 15.06.23 | Novartis Neutral | UBS AG | |
| 13.06.23 | Novartis Buy | Deutsche Bank AG | |
| 09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 06.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Underweight | Barclays Capital | |
| 02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.23 | Novartis Underperform | Credit Suisse Group | |
| 26.04.23 | Novartis Underweight | Barclays Capital | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Buy | Deutsche Bank AG | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
| 14.03.23 | Novartis Sell | Deutsche Bank AG | |
| 17.02.23 | Novartis Sell | Deutsche Bank AG | |
| 13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.23 | Novartis Sell | Deutsche Bank AG | |
| 06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.02.23 | Novartis Underperform | Credit Suisse Group | |
| 02.02.23 | Novartis Sell | Deutsche Bank AG | |
| 01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.23 | Novartis Buy | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 29.09.23 |
RBC Capital Markets Commerzbank Sector Perform |
|
| 29.09.23 |
Baader Bank Sixt Buy |
|
| 29.09.23 |
DZ BANK Nike Halten |
|
| 29.09.23 |
UBS AG Nike Buy |
|
| 29.09.23 |
Merrill Lynch & Co., Inc. Nike Neutral |
|
| 29.09.23 |
Bernstein Research Nike Outperform |
|
| 29.09.23 |
Jefferies & Company Inc. Airbus Hold |